Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00579384 | A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy | PHASE2 | COMPLETED | 12 | — | — | Oct 1, 2007 | Jul 1, 2008 | Apr 5, 2012 | - | — |
| Arm | Type | Description |
|---|---|---|
| 001 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| JNJ-26489112 | DRUG | Single oral dose of JNJ-26489112 up to 3000 mg on Day 2. |
| Placebo | DRUG | Single dose of placebo on Day 1, and a second single dose of placebo on Day 3. |
Inclusion Criteria: * Males or postmenopausal/surgically sterile females. Post-menopausal is defined as no menses for the 18 months prior to study start. If menses have ceased within 36 months of the start of this study, then plasma follicle stimulating hormone must be elevated to within a post-men...